FDA Adverse Event
Injury
Summary report: N
HEARTWARE® VENTRICULAR ASSIST SYSTEM
MDR report key: 2992173
·
Received March 7, 2013
Report
- Report Number
- 3007042319-2013-00027
- Event Type
- Injury
- Date Received
- March 7, 2013
- Date of Event
- December 4, 2012
- Report Date
- December 18, 2012
- Manufacturer
- HEARTWARE, INC
- Product Code
- DSQ
- PMA / PMN Number
- P100047
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
Additional Manufacturer Narrative · 1
PRODUCT REMAINS IMPLANTED.
Description of Event or Problem · 1
THIS EVENT INVOLVED A PATIENT WHO EXPERIENCED RE-OCCURRING "STROKE-LIKE" SYMPTOMS APPROXIMATELY FOUR AND A HALF MONTHS AFTER HEARTWARE LVAD IMPLANTATION. THE PATIENT'S ASPIRIN WAS DECREASED (81MG) AND SHE WAS STARTED ON PLAVIX (75MG). THE PATIENT IS THEN REPORTED TO HAVE DEVELOPED A HEADACHE AND A REPEATED CT REVEALED A SMALL TO MODERATE AMOUNT OF SUBARACHNOID BLOOD BETWEEN THE SULCI OF THE RIGHT HEMISPHERE AND A FOCAL HEMORRHAGE IN THE RIGHT FRONTAL LOBE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 96728 | HEARTWARE® VENTRICULAR ASSIST SYSTEM | CIRCULATORY ASSIST SYSTEM | DSQ | HEARTWARE, INC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R| S | ASPIRIN (325MG) |